Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Geron (GERN)

No earlier versions found for this Subject.

Return to Geron (GERN)

Geron (GERN) is a telomere company, based in Menlo Park. Small market cap but lots of proprietary knowledge of telomeres and telomerase. Telomeres are the DNA bits on the ends of chromosomes that get shorter each time the cell divides. When it divides 50 times ...pffft, cell dies all on its own. Cancer cells turn on telomerase, add back the DNA bits, and obtain a sort of messy immortality, until the "host" dies.

Anyway, though GERN doesnt have an anti-telomerase molecule in clinical trials yet, it will be a barn burner if one is found. About 8 million shares outstanding, went public in July (bad timing) and it closed at 9 today. Comments, info, please.